Trial Profile
Estradiol and Fear Extinction for Calorie-Dense Foods in Weight Restored Adult Women With Anorexia Nervosa (AN)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Estradiol (Primary) ; Medroxyprogesterone
- Indications Anorexia nervosa
- Focus Therapeutic Use
- 22 Aug 2018 Status changed from recruiting to withdrawn prior to enrolment after 18 months due to lack of recruitment.
- 12 Dec 2016 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 12 Dec 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.